Careers
Mineralys Therapeutics Inc, a clinical-stage biopharmaceutical company, focuses on developing medicines to address conditions driven by elevated aldosterone levels. Their product candidate, lorundrostat, is an orally administered, selective aldosterone synthase inhibitor designed for individuals with uncontrolled or resistant hypertension who have difficulty achieving blood pressure targets with multiple antihypertensive medications.
On-site & Remote